Boundless Bio, Inc. (BOLD)

$8.72

-0.88

(-9.17%)

Market is closed - opens 7 PM, 30 May 2024

Performance

  • $8.66
    $9.51
    $8.72
    downward going graph

    0.69%

    Downside

    Day's Volatility :8.94%

    Upside

    8.31%

    downward going graph
  • $8.51
    $15.24
    $8.72
    downward going graph

    2.41%

    Downside

    52 Weeks Volatility :44.16%

    Upside

    42.78%

    downward going graph

Returns

PeriodBoundless Bio, Inc.Index (Russel 2000)
3 Months
-32.63%
0.0%
6 Months
-32.63%
0.0%
1 Year
-32.63%
0.0%
3 Years
-32.63%
-22.0%

Highlights

Market Capitalization
301.1M
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-33.13%
Return On Equity TTM
-52.93%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-53.8M
Diluted Eps TTM
0.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 573.74%

Current $8.72
Target $58.75

Technicals Summary

Sell

Neutral

Buy

Boundless Bio, Inc. is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Boundless Bio, Inc.
Boundless Bio, Inc.
-16.23%
-32.63%
-32.63%
-32.63%
-74.15%
Moderna, Inc.
Moderna, Inc.
37.25%
93.9%
21.76%
-17.04%
605.99%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
9.04%
20.35%
33.57%
93.38%
216.19%
Novo Nordisk A/s
Novo Nordisk A/s
5.67%
31.45%
67.8%
238.63%
470.19%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
12.79%
27.32%
37.37%
113.13%
168.32%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Boundless Bio, Inc.
Boundless Bio, Inc.
NA
NA
NA
0.0
-0.53
-0.33
NA
NA
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.14
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
29.07
29.07
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
47.24
47.24
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
29.67
29.67
0.53
17.14
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Boundless Bio, Inc.
Boundless Bio, Inc.
NA
$301.1M
-74.15%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$63.9B
605.99%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.5B
216.19%
29.07
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$606.0B
470.19%
47.24
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$117.9B
168.32%
29.67
39.46%

Company Information

Organization
Boundless Bio, Inc.
Employees
72
CEO
Dr. Jonathan E. Lim M.D.
Industry
Health Technology

FAQs